Zobrazeno 1 - 10
of 934
pro vyhledávání: '"Hsu JC"'
Publikováno v:
Clinical Interventions in Aging, Vol Volume 8, Pp 301-308 (2013)
Nien-Tzu Chang,1,2,* Yi-Hui Lee,2,3 Jiin-Chyr Hsu,4 Chien-Lung Chan,5 Guey-Shiun Huang,2 Jenn-Huei Renn,1,6,* Nan-Ping Yang1,4,* 1Community Health Research Center and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan; 2Departm
Externí odkaz:
https://doaj.org/article/6e43983998af49a385519efa50471409
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S279-S279
Autor:
Ruperto N, Brunner HI, Ramanan AV, Horneff G, Cuttica R, Henrickson M, Anton J, Boteanu AL, Penades IC, Minden K, Schmeling H, Hufnagel M, Weiss JE, Pardeo M, Nanda K, Roth J, Rubio-Pérez N, Hsu JC, Wimalasundera S, Wells C, Bharucha K, Douglass W, Bao M, Mallalieu NL, Martini A, Lovell D, De Benedetti F, Paediatric Rheumatology INternational Trials Organisation (PRINTO) and the Pedia
Publikováno v:
Rheumatology
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Rheumatology (Oxford, England)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Rheumatology (Oxford, England)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
OBJECTIVES: To determine s.c. tocilizumab (s.c.-TCZ) dosing regimens for systemic JIA (sJIA) and polyarticular JIA (pJIA). METHODS: In two 52-week phase 1 b trials, s.c.-TCZ (162 mg/dose) was administered to sJIA patients every week or every 2 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1a314eb0bd4732c03544a4a95918677d
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18829
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18829
Publikováno v:
15th Congress of the European Forum for Research in Rehabilitation (EFRR); 20190415-20190417; Berlin; DOC089 /20190416/
Background: People with dementia survive an average 8 more years postdiagnosis, and more than 70% caregivers are relatives who provide care at home [ref:1]. Those with mild and moderate dementia and who are cared by relatives dwell in the community,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10672ee80fedc5fc878bc036ffa2a8b1
Autor:
Yang, JC, Hsu, JC, Lai, YL, Chein, YC, Tsai, YC, Hung, LY, Tsai, HT, Chou, CC, Lee, HY, Huang, AC, Lo, CF, Chen, WH
Publikováno v:
15th Congress of the European Forum for Research in Rehabilitation (EFRR); 20190415-20190417; Berlin; DOC107 /20190416/
Background: Exercise intervention is effective to prevent or delay disability in people with dementia [ref:1], however the effects of a community based exercise intervention for a city in Taiwan still needs to be investigated. Aim: To investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d91f549922ee3f2d918c84111c1d10
Autor:
Mallalieu NL, Wimalasundera S, Hsu JC, Douglass W, Wells C, Penades IC, Cuttica R, Huppertz HI, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C
Publikováno v:
PEDIATRIC RHEUMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
The anti-interleukin-6 receptor-alpha antibody tocilizumab was approved for intravenous (IV) injection in the treatment of patients with systemic juvenile idiopathic arthritis (sJIA) aged 2 to 17 years based on results of a randomized controlled phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::33b69f29ac7ee0210c11a3f18289cdf1
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11041
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11041
Publikováno v:
Gut. 51:712-716
Background and aims: The pancreatic cystic neoplasms, including solid pseudopapillary tumour (SPT), mucinous cystic neoplasm (MCN), and intraductal papillary mucin producing tumour (IPMT), have their characteristic clinicopathological features. A sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e171c59c4dafe854f65cc3f6e1381e4
https://doi.org/10.1136/gut.51.5.712
https://doi.org/10.1136/gut.51.5.712
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S112-S112
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S220-S221
Publikováno v:
Marcus, Gregory; Hsu, JC; Varosy, PD; Bao, H; Wang, Y; Curtis, JP; et al.(2012). Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/0gs693g2
Implantable cardioverter-defibrillators (ICDs) are placed in patients at risk for sudden cardiac death, but the procedure may cause adverse events. Patient body habitus may be an important factor responsible for ICD implantation complications. We ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d10aad61a0a3cbad5d08c67d0ab0f846
http://www.escholarship.org/uc/item/0gs693g2
http://www.escholarship.org/uc/item/0gs693g2